Abstract Details

Title Efficacy of NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) in the Treatment of Patients with Focal Dystonia

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 268

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Susanne Grafe, MD (Merz Pharmaceuticals GmbH)	No disclosure on file
Fletcher L. Hartsell III, MD, MPH (Duke Neurology)	No disclosure on file
	No disclosure on file

��ɫ��